(Philadelphia,
PA) – Abass Alavi, MD, Professor of Radiology and Chief
of the Division of Nuclear Medicine at the University of Pennsylvania
Medical Center, has been named the recipient of the 2004 Georg Charles
de Hevesy Nuclear Medicine Pioneer Award from the Society of Nuclear Medicine.
Dr. Alavi was chosen by Dr. Henry Royal, President of the Society, for pioneering
work that has contributed to the advancement of nuclear medicine world-wide.
The award was presented at the 51st Annual Conference of the Society of Nuclear
Medicine during the first plenary session on Sunday, June 20, in Philadelphia,
PA.Each year the Society presents the Georg Charles de Hevesy Nuclear Medicine Pioneer Award to an individual (or individuals) for outstanding contributions to the field of Nuclear Medicine. The award is named after Dr. de Hevesy, who is recognized as the father of nuclear medicine, and is the author of several important books and papers on radiochemistry. Dr. de Hevesy received the 1943 Nobel Prize in Chemistry for his work in determining the absorption, distribution, metabolism and elimination of radioactive compounds in the human body. This research laid the foundation of nuclear medicine as a tool for diagnosis and therapy.
Alavi joined the University of Pennsylvania School of Medicine in 1971 as a research fellow in nuclear medicine after completing his education in internal medicine, hematology and radiology. He soon thereafter was appointed to Penn’s faculty where he currently holds appointments as Professor and Chief, Division of Nuclear Medicine, Department of Radiology. He is also Medical Director of the Positron Emission Topography (PET) Center at the Hospital of the University of Pennsylvania and an internationally recognized expert in modern imaging techniques and the clinical applications of PET imaging for the detection of cancer and other serious disorders including dementia, seizures, cardiovascular disease, and infection.
“Dr. Alavi’s crowning achievement has been his pioneering work in Positron Emission Topography,” said Dr. Royal. “We speak of molecular imaging, and PET specifically, as ‘The Future,’ but he had the foresight to study PET images as early as the 1970s. If you examine nuclear medicine you will find his name. It is with great pleasure that we extend our congratulations to Dr. Alavi on being awarded this prestigious honor.”
Alavi’s contributions to nuclear medicine extend well beyond his own research. He and his wife, Dr. Jane Alavi, have been long-time supporters of educational and research opportunities for students in nuclear medicine. While their names are associated with the Alavi-Mandell Awards, which recognize trainees and young scientists who publish articles as senior authors in the Journal of Nuclear Medicine, their generosity also supports the Pilot Research Grants and the Bradley-Alavi Student Fellowship Awards funded by the Education and Research Foundation for the Society of Nuclear Medicine. The Alavis not only continue to contribute generously to the Foundation but persuade other colleagues to join them in their support of these important endeavors. He is similarly generous with his time: he serves on the Society’s Education and Research Foundation Board of Directors and is also involved in numerous Society activities.
“I am honored that I was selected by the Society of Nuclear Medicine for such a distinction,” said Alavi. “I share this recognition with my family, my mentors, and with so many students with whom I have worked over the past three decades. This is truly a highlight of my career.”
The Society of Nuclear Medicine’s 51st Annual Meeting allows over 3,600 nuclear medicine physicians, scientists, pharmacists, and technologists to share research, learn about the latest breakthroughs and discuss the critical concerns facing nuclear medicine today. Alavi’s group is presenting over 60 scientific communications during the Society’s Annual Meeting. “This is all due to the efforts of my wonderful students who work in our group,” he explained. “I am very proud of the contributions of these young talents.”
The Society of Nuclear Medicine is an international scientific and professional organization founded in 1954 to promote the science, technology and practical application of nuclear medicine. Its 15,000 members are physicians, technologists and scientists specializing in the research and practice of nuclear medicine. In addition to publishing journals, newsletters and books, the Society also sponsors international meetings and workshops designed to increase the competencies of nuclear medicine practitioners and to promote new advances in the science of nuclear medicine.